BRISBANE, Calif. --(BUSINESS WIRE)--Jan. 9, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae , CEO of Sangamo, will present a corporate overview at the 38 th Annual J.P. Morgan Healthcare Conference on Thursday, January 16 th at 8:30
